ARMR Systems develops hemorrhage control systems designed to increase the survivability of traumatic battlefield injury in situations where advanced medical support is not immediately available.
Portfolio Companies
Company News
December 31, 2020
BioBuzz End of Year Update: 2020 Life Science Venture Capital Funding Roundup in the BioHealth Capital Region
This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a few months into 2020, the coronavirus pandemic swept the…
- MMF Press / Media
- Portfolio Company News
December 7, 2020
Entrepreneurial Spirit: UMB Startups Receive Support from Maryland Momentum Fund
The University of Maryland, Baltimore (UMB) strives to support the entrepreneurial talents of its students, faculty, staff, and alumni as it works to improve the human condition and serve the public…
- MMF Press / Media
- Portfolio Company News
February 10, 2020
Technical.ly Baltimore: ARMR Systems raises $750K, with funding from Maryland investors
The University of Maryland BioPark-based company moved to Baltimore in 2017. Now it's looking to continue growing a team as it moves its device to market. Two years ago, ARMR Systems moved to…
- Portfolio Company News
February 10, 2020
USM Maryland Momentum Fund Invests in ARMR Systems
University of Maryland BioPark-based startup is creating a next generation wearable tourniquet device to stop severe arterial bleeds and help increase the survivability of traumatic injury.
- MMF Release
- Portfolio Company News
February 10, 2020
The Daily Record: USM fund invests $350,000 in BioPark med-tech startup
The University System of Maryland Maryland Momentum Fund and the University of Maryland, Baltimore, have invested $350,000 in a medical technology startup, the 11th investment from the fund.…
- MMF Press / Media
- Portfolio Company News